RNAi Digest – August 2020 RNAi Digest – August 2020 Alnylam submits clinical trial authorization (CTA) application for ALN-HSD for the Treatment of Nonalcoholic Steatohepatitis (NASH) 3 Aug 2020 ALN-HSD (siRNA targeting HSD17B13) – Alnylam Pharma/ Regeneron Submitted a clinical […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id